Search by Drug Name or NDC

    NDC 00591-2512-60 bosentan 125 mg/1 Details

    bosentan 125 mg/1

    bosentan is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Actavis Pharma, Inc.. The primary component is BOSENTAN.

    Product Information

    NDC 00591-2512
    Product ID 0591-2512_b2fcbca4-83a2-45c2-bced-eed50865af00
    Associated GPIs 40160015000330
    GCN Sequence Number 048987
    GCN Sequence Number Description bosentan TABLET 125 MG ORAL
    HIC3 B1B
    HIC3 Description PULMONARY ANTI-HTN, ENDOTHELIN RECEPTOR ANTAGONIST
    GCN 14978
    HICL Sequence Number 022990
    HICL Sequence Number Description BOSENTAN
    Brand/Generic Generic
    Proprietary Name bosentan
    Proprietary Name Suffix n/a
    Non-Proprietary Name bosentan
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 125
    Active Ingredient Units mg/1
    Substance Name BOSENTAN
    Labeler Name Actavis Pharma, Inc.
    Pharmaceutical Class Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Endothelin Receptor Antagonist [EPC], Endothelin Receptor Antagonists [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA207110
    Listing Certified Through 2024-12-31

    Package

    NDC 00591-2512-60 (00591251260)

    NDC Package Code 0591-2512-60
    Billing NDC 00591251260
    Package 60 TABLET, FILM COATED in 1 BOTTLE (0591-2512-60)
    Marketing Start Date 2019-06-19
    NDC Exclude Flag N
    Pricing Information N/A